Publication Date
9-1-2021
Journal
Cancer Discovery
DOI
10.1158/2159-8290.CD-20-1066
PMID
33741710
PMCID
PMC8418998
PubMedCentral® Posted Date
3-1-2022
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Animals, DNA-Binding Proteins, Disease Models, Animal, Ependymoma, Mice, Supratentorial Neoplasms, Transcription Factor RelA, Transcription Factors
Abstract
Over 60% of supratentorial (ST) ependymomas harbor a ZFTA-RELA (ZRfus) gene fusion (formerly C11orf95-RELA). To study the biology of ZRfus, we developed an autochthonous mouse tumor model using in utero electroporation (IUE) of the embryonic mouse brain. Integrative epigenomic and transcriptomic mapping was performed on IUE driven ZRfus tumors by CUT&RUN, ChIP, ATAC, and RNA sequencing and compared to human ZRfus driven ependymoma. In addition to direct canonical NF-κB pathway activation, ZRfus dictates a neoplastic transcriptional program and binds to thousands of unique sites across the genome that are enriched with Plagl family transcription factor (TF) motifs. ZRfus activates gene expression programs through recruitment of transcriptional co-activators (Brd4, Ep300, Cbp, Pol2) that are amenable to pharmacologic inhibition. Downstream ZRfus target genes converge on developmental programs marked by Plagl transcription factor proteins, and activate neoplastic programs enriched in Mapk, focal adhesion, and gene imprinting networks.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Medical Sciences Commons, Medical Specialties Commons
Comments
Associated Data